Evidence map›Paper›PMID 10100729›Full record

ArticleThe Histochemical journal1998

Epidermal cell kinetics by combining in situ hybridization and immunohistochemistry.

F A Castelijns, J Ezendam, M A Latijnhouwers, I M Van Vlijmen-Willems, P L Zeeuwin, M J Gerritsen, P C Van de Kerkhof, P E Van Erp

Abstract read
PubMed Publisher
In one paragraph

Article in The Histochemical journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Modelling epidermis homoeostasis and psoriasis pathogenesis.Journal of the Royal Society, Interface · 2015
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

F A CastelijnsDepartment of Dermatology, University Hospital Nijmegen, The Netherlands.
J Ezendam
M A Latijnhouwers
I M Van Vlijmen-Willems
P L Zeeuwin
M J Gerritsen
P C Van de Kerkhof
P E Van Erp
Radboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Double labelling can serve as a useful tool for providing information about cell kinetics in normal and hyperproliferative tissues in general, and skin in particular. We have developed a double-labelling method that combines immunohistochemistry using the monoclonal antibody MIB1 and non-isotopic in situ hybridization using either a digoxigenin-labelled RNA probe specific for histone 3 mRNA sequences or a Fluorescein-labelled oligonucleotide probe specific for histone 2b, 3, 4 mRNA sequences. Double labelling was performed on normal, tape-stripped normal skin and psoriatic skin. The three proliferation markers were also examined by single labelling. The ratio of cells in the S-phase (Ns) and the growth fraction (Ncy) was determined. In normal skin, psoriatic skin and tape-stripped normal skin after 24 h and after 48 h, we calculated that 15%, 16%, 3% and 12% of growth fraction consisted of cells in the S-phase respectively. The S-phase lasts approximately 10 h, so the cell cycle time in normal and psoriatic skin is approximately 62.5 h. At present, the MIB1/H3 digoxigenin or MIB1/H2b-H3-H4 Fluorescein double-labelling technique cannot be used routinely. Therefore, in order to understand the cell kinetic processes better, experiments are recommended to optimize these methods. From a practical point of view and for reasons of specificity and sensitivity, we prefer the Fluorescein-labelled oligonucleotide probe method.

Indexed as

Epidermal CellsCell DivisionDigoxigeninDNA, ComplementaryEpidermisFluorescein-5-isothiocyanateHistonesHumansImmunohistochemistryIn Situ HybridizationKi-67 AntigenKineticsOligonucleotide ProbesSkinStatistics as TopicDigoxigeninDNA, ComplementaryFluorescein-5-isothiocyanateHistonesKi-67 AntigenOligonucleotide Probes

Identifiers

PMID10100729
OpenAlexW1510230317

What OpenQuestion holds

Texttitle and abstract
measurements read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.